Investor directory

Anzu Partners

Anzu Partners is a venture capital and private equity firm based in Washington, D.C., that specializes in early-stage investments in breakthrough industrial and life science technology companies across the United States and Canada. Founded in 2014 by Whitney Haring-Smith, David Michael, and David Seldin, the firm partners with entrepreneurs to develop and commercialize technological innovations. Anzu provides not only capital but also extensive expertise in business development, market positioning, global connectivity, and operations. The firm's portfolio support platform aims to drive results that extend beyond initial investments, fostering long-term relationships with the companies it supports.
http://www.anzupartners.com
https://crunchbase.com/organization/anzu-partner
https://linkedin.com/company/anzupartners
https://signal.nfx.com/firms/anzu-partners
https://twitter.com/anzupartners
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=303689233
https://www.privateequityinternational.com/database/#/profile?id=18020

Jenna Abelli

Principal

Wendi Carter

Controller

R. David Edelman

Venture Partner

Carl Eibl

Venture Partner

Rob Haralson

Principal, Strategic Communications and Government Relations

Jimmy Kan Ph.D

Partner

Jaione Maiz Ph.D

Principal

David Michael

Managing Partner

Cathryn Paine

Principal, People

Gray Robinson

Senior Associate

David Seldin

Managing Partner

William H. Strong

Partner

Past deals in Albuquerque, NM

BioFlyte

Series A in 2022
BioFlyte specializes in the development of advanced bio-threat detection devices aimed at safeguarding against biological and low-volatility chemical threats. The company's innovative aerosol mass spectrometers are capable of autonomously sampling ambient air in critical environments, while also allowing for the manual analysis of liquid or powder samples. These instruments can identify a range of threats, including microbes, bio-toxins, and airborne chemicals, providing timely alerts to users about potential dangers. BioFlyte's technologies are designed to enhance safety and security by enabling effective responses to bio-chemical risks.

BioFlyte

Seed Round in 2020
BioFlyte specializes in the development of advanced bio-threat detection devices aimed at safeguarding against biological and low-volatility chemical threats. The company's innovative aerosol mass spectrometers are capable of autonomously sampling ambient air in critical environments, while also allowing for the manual analysis of liquid or powder samples. These instruments can identify a range of threats, including microbes, bio-toxins, and airborne chemicals, providing timely alerts to users about potential dangers. BioFlyte's technologies are designed to enhance safety and security by enabling effective responses to bio-chemical risks.